Year archive

Galapagos NV — 2024 filings

All 118 regulatory filings released by Galapagos NV (GLPG) in 2024, sourced directly from the official regulator.

118 Filings

2024 Period

2024 filings (118)

Filing	Released	Lang
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma Earnings Release Q2 2024	2024-12-09	Dutch
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma Earnings Release Q2 2024	2024-12-09	Dutch
6-K Filing Foreign Filer Report	2024-12-09	English
S-8 Filing Registration Form	2024-11-20	English
SC 13G/A Filing Major Shareholding Notification	2024-11-12	English
Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 Earnings Release Q2 2024	2024-11-06	Dutch
Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 Regulatory Filings	2024-11-06	English
6-K Filing Foreign Filer Report	2024-11-06	English
Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update Earnings Release 9M 2024	2024-10-31	English
Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update Interim / Quarterly Report 9M 2024	2024-10-31	Dutch
6-K Filing Foreign Filer Report	2024-10-31	English
Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update.pdf Earnings Release 9M 2024	2024-10-30	English
Galapagos rapporteert financiële resultaten over het derde kwartaal van 2024 en geeft een bedrijfsupdate.pdf Interim / Quarterly Report 9M 2024	2024-10-30	Dutch
SC 13D/A Filing Major Shareholding Notification	2024-10-08	English
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth Board/Management Information	2024-10-07	Dutch
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth Board/Management Information	2024-10-07	English
6-K Filing Foreign Filer Report	2024-10-07	English
Galapagos ontvangt transparantieverklaring van EcoR1 Capital Major Shareholding Notification	2024-10-01	English
Galapagos ontvangt transparantieverklaring van EcoR1 Capital Major Shareholding Notification	2024-10-01	Dutch
26092024 EcoR1 Capital Galapagos tr-1be-FINAL_Redacted (1).pdf Major Shareholding Notification	2024-09-30	English
Galapagos receives transparency notification from EcoR1 Capital.pdf Major Shareholding Notification	2024-09-30	English
Galapagos ontvangt transparantieverklaring van EcoR1 Capital.pdf Major Shareholding Notification	2024-09-30	Dutch
6-K Filing Foreign Filer Report	2024-09-30	English
Galapagos receives transparency notification from EcoR1 Capital Major Shareholding Notification	2024-09-17	English
Galapagos receives transparency notification from EcoR1 Capital Major Shareholding Notification	2024-09-17	Dutch
Galapagos receives transparency notification from EcoR1 Capital.pdf Major Shareholding Notification	2024-09-16	English
Galapagos ontvangt transparantieverklaring van EcoR1 Capital.pdf Major Shareholding Notification	2024-09-16	Dutch
6-K Filing Foreign Filer Report	2024-09-16	English
Galapagos receives transparency notification from FMR LLC Major Shareholding Notification	2024-09-04	Dutch
Galapagos receives transparency notification from FMR LLC Major Shareholding Notification	2024-09-04	English
GLPG EN PR_FMR LLC 30 August 2024_ENG.pdf Major Shareholding Notification	2024-09-03	English
GLPG EN PR_FMR LLC 30 August 2024_NL.pdf Major Shareholding Notification	2024-09-03	Dutch
6-K Filing Foreign Filer Report	2024-09-03	English
Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma Regulatory Filings	2024-08-23	Dutch
Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma Regulatory Filings	2024-08-23	English
GLPG Press Release IND Clearance_ENG_FINAL.pdf Regulatory Filings	2024-08-23	English
GLPG Press Release IND Clearance_NL_FINAL.pdf Regulatory Filings	2024-08-23	Dutch
6-K Filing Foreign Filer Report	2024-08-23	English
SC 13D Filing Major Shareholding Notification	2024-08-23	English
Galapagos ontvangt transparantieverklaring van FMR LLC Major Shareholding Notification	2024-08-21	Dutch
Galapagos ontvangt transparantieverklaring van FMR LLC Major Shareholding Notification	2024-08-21	English
6-K Filing Foreign Filer Report	2024-08-21	English
GLPG Press Release FMR TN_240820_ENG.pdf Major Shareholding Notification	2024-08-20	English
GLPG Press Release FMR TN_240820_NL.pdf Major Shareholding Notification	2024-08-20	Dutch
Galapagos reports half-year 2024 financial results and provides second quarter business update Earnings Release H1 2024	2024-08-02	English
Galapagos reports half-year 2024 financial results and provides second quarter business update Interim / Quarterly Report H1 2024	2024-08-02	Dutch
6-K Filing Foreign Filer Report	2024-08-02	English
Galapagos reports half-year 2024 financial results and provides second quarter business update.pdf Earnings Release H1 2024	2024-08-01	English
Galapagos rapporteert halfjaarcijfers 2024 en geeft een update over de activiteiten in het tweede kwartaal.pdf Interim / Quarterly Report H1 2024	2024-08-01	Dutch
Half-year report 2024.pdf Interim / Quarterly Report H1 2024	2024-08-01	English
Halfjaarverslag 2024.pdf Interim / Quarterly Report H1 2024	2024-08-01	Dutch
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024 Earnings Release Q4 2023	2024-06-17	Dutch
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024 Regulatory Filings	2024-06-17	English
6-K Filing Foreign Filer Report	2024-06-17	English
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future so Capital/Financing Update	2024-05-31	Dutch
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future so Regulatory Filings	2024-05-31	English
glpg-press-release-adap-collaboration-eng-30-may-2024 (3).pdf Regulatory Filings	2024-05-30	English
glpg-press-release-adap-collaboration-nl-30-may-2024 (2).pdf Capital/Financing Update	2024-05-30	Dutch
6-K Filing Foreign Filer Report	2024-05-30	English
Galapagos creates new subscription right plans Share Issue/Capital Change	2024-05-17	Dutch
Galapagos creates new subscription right plans Share Issue/Capital Change	2024-05-17	English
press-release-subscription-right-plans-2024-eng.pdf Share Issue/Capital Change	2024-05-16	English
press-release-subscription-right-plans-2024-nl.pdf Share Issue/Capital Change	2024-05-16	Dutch
6-K Filing Foreign Filer Report	2024-05-16	English
6-K Filing Foreign Filer Report	2024-05-16	English
Galapagos reports first quarter 2024 financial results Interim / Quarterly Report Q1 2024	2024-05-03	English
Galapagos reports first quarter 2024 financial results Earnings Release Q1 2024	2024-05-03	Dutch
6-K Filing Foreign Filer Report	2024-05-03	English
Galapagos reports first quarter 2024 financial results.pdf Earnings Release Q1 2024	2024-05-02	English
Galapagos rapporteert financiële resultaten voor het eerste kwartaal 2024.pdf Earnings Release Q1 2024	2024-05-02	Dutch
Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024 AGM Information	2024-05-01	Dutch
Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024 AGM Information	2024-05-01	English
6-K Filing Foreign Filer Report	2024-05-01	English
6-K Filing Foreign Filer Report	2024-05-01	English
6-K Filing Foreign Filer Report	2024-04-08	English
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 Regulatory Filings	2024-04-05	Dutch
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 Regulatory Filings	2024-04-05	English
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings Report Publication Announcement	2024-03-29	Dutch
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings Report Publication Announcement	2024-03-29	English
6-K Filing Foreign Filer Report	2024-03-29	English
6-K Filing Foreign Filer Report	2024-03-29	English
Convening-Notice-ENG-FINAL611365.1.pdf Proxy Solicitation & Information Statement	2024-03-28	English
Convening-Notice-NL_FINAL611364.1.pdf Proxy Solicitation & Information Statement	2024-03-28	Dutch
Sustainability Report 2023.pdf Environmental & Social Information	2024-03-28	English
Duurzaamheidsverslag 2023.pdf Environmental & Social Information	2024-03-28	Dutch
Annual report 2023.pdf Annual Report FY 2023	2024-03-28	English
Jaarverslag 2023.pdf Annual Report FY 2023	2024-03-28	Dutch
699400FG6E2AD50YHF38-2023-12-31-nl.xhtml Annual Report FY 2023	2024-03-28	Dutch
699400FG6E2AD50YHF38-2023-12-31-nl (5).zip Annual Report (ESEF) FY 2023	2024-03-28	Dutch
20-F Filing Annual Report FY 2023	2024-03-28	English
Galapagos benoemt Andrew Dickinson tot Niet-Uitvoerend, Niet-Onafhankelijk Bestuurder van haar Raad van Bestuur Board/Management Information	2024-03-27	Dutch
Galapagos benoemt Andrew Dickinson tot Niet-Uitvoerend, Niet-Onafhankelijk Bestuurder van haar Raad van Bestuur Board/Management Information	2024-03-27	English
Galapagos announces full year 2023 results and outlook for 2024 Earnings Release FY 2023	2024-02-23	English
Galapagos announces full year 2023 results and outlook for 2024 Annual Report FY 2023	2024-02-23	English
Galapagos kondigt 2023 jaarresultaten en vooruitzichten 2024 aan Earnings Release FY 2023	2024-02-23	Dutch
Galapagos kondigt 2023 jaarresultaten en vooruitzichten 2024 aan Audit Report / Information FY 2023	2024-02-23	Dutch
6-K Filing Foreign Filer Report	2024-02-23	English
fy23_financial_tables_en.pdf Annual Report FY 2023	2024-02-22	English
fy23_financial_tables_nl.pdf Audit Report / Information FY 2023	2024-02-22	Dutch
Galapagos announces full year 2023 results and outlook for 2024.pdf Earnings Release FY 2023	2024-02-22	English
Galapagos kondigt 2023 jaarresultaten en vooruitzichten 2024 aan.pdf Earnings Release FY 2023	2024-02-22	Dutch
Galapagos presents at EBMT-EHA annual meeting 2024 Investor Presentation	2024-02-16	English
Galapagos presents at EBMT-EHA annual meeting 2024 Investor Presentation	2024-02-16	Dutch
6-K Filing Foreign Filer Report	2024-02-16	English
SC 13G/A Filing Major Shareholding Notification	2024-02-14	English
SC 13G/A Filing Major Shareholding Notification	2024-02-09	English
6-K Filing Foreign Filer Report	2024-02-06	English
Galapagos rondt transactie af om Jyseleca® business over te dragen aan Alfasigma M&A Activity	2024-02-01	English
Galapagos rondt transactie af om Jyseleca® business over te dragen aan Alfasigma M&A Activity	2024-02-01	Dutch
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S. Regulatory Filings	2024-01-05	Dutch
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S. Regulatory Filings	2024-01-05	English
6-K Filing Foreign Filer Report	2024-01-05	English
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology Regulatory Filings	2024-01-04	Dutch
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology Regulatory Filings	2024-01-04	English
6-K Filing Foreign Filer Report	2024-01-04	English
6-K Filing Foreign Filer Report	2024-01-04	English
Galapagos signs agreement to transfer Jyseleca® business to Alfasigma M&A Activity	2024-01-02	Dutch
Galapagos signs agreement to transfer Jyseleca® business to Alfasigma M&A Activity	2024-01-02	English

Filings by year

2026 99 filings
2025 162 filings
2024 118 filings
2023 121 filings
2022 167 filings
2021 183 filings
2020 156 filings
2019 324 filings
2018 205 filings
2017 196 filings
2016 217 filings
2015 187 filings
2014 183 filings
2013 142 filings
2012 105 filings
2011 124 filings
2010 42 filings
2009 39 filings
2008 31 filings
2007 27 filings
2006 15 filings
2005 12 filings